NVCT
Nuvectis Pharma
$19.54
+$0.23 (+1.19%)Jul 27, 2026
Key metrics
The numbers that frame NVCT today
- Market cap
- $518.31M
- P/E (TTM)
- -19.1
- EV / FCF
- -26.9
- ROIC
- 238.9%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $5.55
- 52wk High
- $29.28
Growth
Revenue and earnings trend for NVCT
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about NVCT
Is Nuvectis Pharma a good buy?
Hold. Nuvectis Pharma has excellent momentum, but poor quality makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think Nuvectis Pharma is selling at a high price.
What is the market capitalization of NVCT?
Nuvectis Pharma's market capitalization is $518.31M.
What is the P/E ratio for NVCT stock?
Nuvectis Pharma's current P/E ratio is -19.1.
What is the 52-week high for NVCT stock?
The 52-week high for Nuvectis Pharma is $29.28. The current close of $19.54 is 33.3% below that high.
What is the 52-week low for NVCT stock?
The 52-week low for Nuvectis Pharma is $5.55. The current close of $19.54 is 252.1% above that low.
Does NVCT stock pay dividends?
Nuvectis Pharma does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for NVCT?
Nuvectis Pharma's Debt / Equity ratio is 0.